• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸道合胞病毒感染对先天性心脏畸形患儿的急性和长期影响。

Acute and long-term effects of infection by the respiratory syncytial virus in children with congenital cardiac malformations.

作者信息

Feltes Timothy F, Groothuis Jessie R

机构信息

Section of Pediatric Cardiology, Ohio State University, Columbus, OH 43205, USA.

出版信息

Cardiol Young. 2005 Jun;15(3):266-73. doi: 10.1017/S1047951105000557.

DOI:10.1017/S1047951105000557
PMID:15865828
Abstract

All newborn infants have limited pulmonary reserve compared with older children. This puts them at increased risk of respiratory complications, such as those associated with infection by the respiratory syncytial virus. Young children with congenital cardiac disease are particularly likely to suffer severe disease related to infection by the virus. In these children, the extreme vulnerability of the lung to pulmonary oedema is compounded by the additional burden caused by the respiratory syncytial virus. In addition to the well-documented acute pulmonary effects of infection with the respiratory syncytial virus, there may also be consequent long-term respiratory morbidity. Clinical studies have shown that infection by the virus in infancy is associated with a higher risk of developing subsequent bronchial obstructive disease. Much debate surrounds the mechanisms underlying this association. It is thought that a combined immunological and neurogenic response mechanism is likely. Prevention of severe respiratory disease in infants and young children with congenital heart disease due to infection by the virus may, therefore, offer both immediate and long-term benefits. Indeed, an increasing body of evidence supports this hypothesis, indicating a clinical rationale for prophylaxis against the virus in infancy, in order to reduce the chance of developing reactive airways disease and asthma in later life.

摘要

与大龄儿童相比,所有新生儿的肺储备功能都有限。这使他们发生呼吸并发症的风险增加,比如与呼吸道合胞病毒感染相关的并发症。患有先天性心脏病的幼儿尤其容易患上与该病毒感染相关的严重疾病。在这些儿童中,肺部对肺水肿的极度易损性因呼吸道合胞病毒造成的额外负担而加剧。除了呼吸道合胞病毒感染有充分记录的急性肺部影响外,还可能会有随之而来的长期呼吸道疾病。临床研究表明,婴儿期感染该病毒与日后发生支气管阻塞性疾病的风险较高有关。围绕这种关联背后的机制存在很多争论。人们认为可能是免疫和神经源性联合反应机制。因此,预防患有先天性心脏病的婴幼儿因该病毒感染而发生严重呼吸道疾病可能会带来即时和长期的益处。确实,越来越多的证据支持这一假设,表明在婴儿期预防该病毒有临床依据,以降低日后发生反应性气道疾病和哮喘的几率。

相似文献

1
Acute and long-term effects of infection by the respiratory syncytial virus in children with congenital cardiac malformations.呼吸道合胞病毒感染对先天性心脏畸形患儿的急性和长期影响。
Cardiol Young. 2005 Jun;15(3):266-73. doi: 10.1017/S1047951105000557.
2
The European Forum for Clinical Management: prophylaxis against the respiratory syncytial virus in infants and young children with congenital cardiac disease.欧洲临床管理论坛:先天性心脏病婴幼儿呼吸道合胞病毒的预防
Cardiol Young. 2005 Jun;15(3):274-8. doi: 10.1017/S1047951105000569.
3
Infection by the respiratory syncytial virus in infants and young children at high risk.呼吸道合胞病毒在高危婴幼儿中的感染。
Cardiol Young. 2005 Jun;15(3):256-65. doi: 10.1017/S1047951105000545.
4
Recommendations for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease.关于使用帕利珠单抗预防先天性心脏病婴儿呼吸道合胞病毒感染的建议。
Cardiol Young. 2003 Oct;13(5):420-3.
5
[Use of palivizumab for the prevention of respiratory syncytial virus infections in children with congenital heart disease. Recommendations from the French Paediatric Cardiac Society].[帕利珠单抗用于预防先天性心脏病儿童呼吸道合胞病毒感染。法国儿科学会的建议]
Arch Pediatr. 2004 Nov;11(11):1402-5. doi: 10.1016/j.arcped.2004.06.007.
6
Respiratory infection in congenital cardiac disease. Hospitalizations in young children in Spain during 2004 and 2005: the CIVIC Epidemiologic Study.先天性心脏病中的呼吸道感染。2004年和2005年西班牙幼儿住院情况:CIVIC流行病学研究
Cardiol Young. 2007 Aug;17(4):360-71. doi: 10.1017/S104795110700042X.
7
Nationwide survey of palivizumab for respiratory syncytial virus prevention in Japanese children with congenital heart disease.日本先天性心脏病患儿使用帕利珠单抗预防呼吸道合胞病毒的全国性调查。
Pediatr Infect Dis J. 2008 Dec;27(12):1108-9. doi: 10.1097/INF.0b013e3181801d76.
8
Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection.呼吸道合胞病毒感染的抗病毒和抗炎治疗前景
Expert Rev Anti Infect Ther. 2005 Dec;3(6):945-55. doi: 10.1586/14787210.3.6.945.
9
Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization.利巴韦林用于治疗呼吸道合胞病毒细支气管炎可降低哮喘和过敏原致敏风险。
Pediatr Allergy Immunol. 2008 Mar;19(2):166-72. doi: 10.1111/j.1399-3038.2007.00610.x.
10
The impact of infection with human metapneumovirus and other respiratory viruses in young infants and children at high risk for severe pulmonary disease.人偏肺病毒及其他呼吸道病毒感染对严重肺部疾病高危的年幼儿童的影响。
J Infect Dis. 2006 Jun 1;193(11):1544-51. doi: 10.1086/503806. Epub 2006 Apr 27.

引用本文的文献

1
Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey.先天性心脏病患儿的呼吸道合胞病毒感染:全球数据及韩国呼吸道合胞病毒-先天性心脏病调查的中期结果
Korean J Pediatr. 2011 May;54(5):192-6. doi: 10.3345/kjp.2011.54.5.192. Epub 2011 May 31.